(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure...
Stats | |
---|---|
今日成交量 | 435 741 |
平均成交量 | 433 463 |
市值 | 10.98B |
EPS | €0 ( 2024-02-19 ) |
下一个收益日期 | ( €0.550 ) 2024-05-06 |
Last Dividend | €1.120 ( 2023-05-17 ) |
Next Dividend | €0 ( N/A ) |
P/E | 22.01 |
ATR14 | €0.0210 (0.06%) |
音量 相关性
Fresenius Medical Care AG 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Fresenius Medical Care AG 相关性 - 货币/商品
Fresenius Medical Care AG 财务报表
Annual | 2023 |
营收: | €19.45B |
毛利润: | €4.93B (25.32 %) |
EPS: | €1.700 |
FY | 2023 |
营收: | €19.45B |
毛利润: | €4.93B (25.32 %) |
EPS: | €1.700 |
FY | 2022 |
营收: | €19.40B |
毛利润: | €5.31B (27.37 %) |
EPS: | €2.30 |
FY | 2021 |
营收: | €17.62B |
毛利润: | €5.08B (28.82 %) |
EPS: | €3.30 |
Financial Reports:
No articles found.
Fresenius Medical Care AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€1.120 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.230 | 2000-05-31 |
Last Dividend | €1.120 | 2023-05-17 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 26 | -- |
Total Paid Out | €18.29 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.16 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.95 | |
Div. Directional Score | 8.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ZOE.DE | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
GIL.DE | Ex Dividend Junior | 2023-05-15 | Annually | 0 | 0.00% | |
PRU.DE | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
BEZ.DE | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
IBM.DE | Ex Dividend Knight | 2023-08-09 | Quarterly | 0 | 0.00% | |
SNW.DE | Ex Dividend Knight | 2023-05-30 | Annually | 0 | 0.00% | |
CPIA.F | No Dividend Player | 2023-06-29 | Annually | 0 | 0.00% | |
LHOG.F | Ex Dividend Junior | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
185.DE | Ex Dividend Junior | 2023-08-07 | Quarterly | 0 | 0.00% | |
UTDI.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0281 | 1.500 | 9.44 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0161 | 1.200 | 9.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0398 | 1.500 | -0.669 | -1.004 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.424 | 0.800 | 7.88 | 6.30 | [1 - 3] |
quickRatioTTM | 0.916 | 0.800 | 9.32 | 7.45 | [0.8 - 2.5] |
cashRatioTTM | 0.230 | 1.500 | 9.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.355 | -1.500 | 4.08 | -6.12 | [0 - 0.6] |
interestCoverageTTM | 3.47 | 1.000 | 9.83 | 9.83 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.96 | 2.00 | 7.01 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 6.63 | 2.00 | 6.69 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.885 | -1.500 | 6.46 | -9.69 | [0 - 2.5] |
grossProfitMarginTTM | 0.253 | 1.000 | 9.11 | 9.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0710 | 1.000 | -0.580 | -0.580 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.218 | 1.000 | 9.90 | 9.90 | [0.2 - 2] |
assetTurnoverTTM | 0.573 | 0.800 | 9.51 | 7.61 | [0.5 - 2] |
Total Score | 11.04 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 20.09 | 1.000 | 8.07 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0398 | 2.50 | -0.430 | -1.004 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.63 | 2.00 | 7.79 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.99 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.96 | 2.00 | 7.01 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.662 | 1.500 | 2.25 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.135 | 1.000 | 9.12 | 0 | [0.1 - 0.5] |
Total Score | 4.95 |
Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。